281 related articles for article (PubMed ID: 31284427)
1. Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo.
Cao C; Zhou JY; Xie SW; Guo XJ; Li GT; Gong YJ; Yang WJ; Li Z; Zhong RH; Shao HH; Zhu Y
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284427
[TBL] [Abstract][Full Text] [Related]
2. Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a.
Ma AY; Xie SW; Zhou JY; Zhu Y
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640224
[TBL] [Abstract][Full Text] [Related]
3. Thyroid Hormone Receptor β Knockdown Reduces Suppression of Progestins by Activating the mTOR Pathway in Endometrial Cancer Cells.
Ren B; Zhou J; Hu Y; Zhong R; Lv Q; Xie S; Li G; Yang B; Chen X; Zhu Y
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293372
[TBL] [Abstract][Full Text] [Related]
4. An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells.
Shields-Botella J; Duc I; Duranti E; Puccio F; Bonnet P; Delansorne R; Paris J
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):111-22. PubMed ID: 14672731
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.
Kokabu T; Mori T; Matsushima H; Yoriki K; Kataoka H; Tarumi Y; Kitawaki J
Cell Oncol (Dordr); 2019 Apr; 42(2):223-235. PubMed ID: 30706380
[TBL] [Abstract][Full Text] [Related]
6. Effects and Mechanisms of Metformin on the Proliferation of Esophageal Cancer Cells
Tang JC; An R; Jiang YQ; Yang J
Cancer Res Treat; 2017 Jul; 49(3):778-789. PubMed ID: 27857021
[TBL] [Abstract][Full Text] [Related]
7. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
[TBL] [Abstract][Full Text] [Related]
8. MET Inhibits the Proliferation of EC Cells by Increasing MPA Sensitivity.
Sun F; Zhou J; Hao Y; Kuang L; Zhang B
Altern Ther Health Med; 2023 Jul; 29(5):334-341. PubMed ID: 37171945
[TBL] [Abstract][Full Text] [Related]
9. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435
[TBL] [Abstract][Full Text] [Related]
10. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
11. Combination of metformin and RG7388 enhances inhibition of growth and induction of apoptosis of ovarian cancer cells through the PI3K/AKT/mTOR pathway.
Cui Y; Zhou J; Rong F
Biochem Biophys Res Commun; 2020 Dec; 533(4):665-671. PubMed ID: 33051060
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative.
van Diepen HA
Reprod Biol Endocrinol; 2012 Oct; 10():85. PubMed ID: 23043680
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of biodegradable microspheres containing nomegestrol acetate in a rat model of endometriosis.
Zhang J; Zhu Y; Zhou X; Hao S; Xie S; Zhou J; Guo X; Li Z; Huang Y; Chen Q
Eur J Pharm Sci; 2014 Dec; 65():15-20. PubMed ID: 25201168
[TBL] [Abstract][Full Text] [Related]
14. Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth.
Kim JS; Turbov J; Rosales R; Thaete LG; Rodriguez GC
Gynecol Oncol; 2019 Aug; 154(2):432-440. PubMed ID: 31178149
[TBL] [Abstract][Full Text] [Related]
15. [Actions of a 19-norprogesterone derivative on mammary gland: nomegestrol acetate].
André G
J Gynecol Obstet Biol Reprod (Paris); 2005 Feb; 34(1 Pt 1):69-84. PubMed ID: 15767920
[TBL] [Abstract][Full Text] [Related]
16. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
17. Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts.
He L; Guo S; Zhu T; Chen C; Xu K
Med Sci Monit; 2020 Jun; 26():e922561. PubMed ID: 32594094
[TBL] [Abstract][Full Text] [Related]
18. [Nomegestrol acetate: clinical pharmacology].
Lello S
Minerva Ginecol; 2009 Oct; 61(5):459-63. PubMed ID: 19749678
[TBL] [Abstract][Full Text] [Related]
19. Metformin reduces pancreatic cancer cell proliferation and increases apoptosis through MTOR signaling pathway and its dose-effect relationship.
Zhao HW; Zhou N; Jin F; Wang R; Zhao JQ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5336-5344. PubMed ID: 32495867
[TBL] [Abstract][Full Text] [Related]
20. Isolation, synthesis, and cytotoxicity evaluation of two impurities in nomegestrol acetate.
Xie BC; Song SY; Xie XY; Sun YT; Zhang XY; Xu DH; Huang YS
Arch Pharm (Weinheim); 2019 Mar; 352(3):e1800295. PubMed ID: 30600539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
